Oncologix Tech Inc. has purchased all of the outstanding common stock of Dotolo Research Corporation. Wayne Erwin, CEO of Dotolo, who now has been elected Chairman and CEO of Oncologix.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0002 USD | 0.00% | 0.00% | -92.00% |
2022 | DNAGO.Ai entered into a definitive business combination agreement to acquire Oncologix Tech, Inc. in a reverse merger transaction. | CI |
2016 | Oncologix Tech, Inc. Announces Management Changes | CI |
1st Jan change | Capi. | |
---|---|---|
-92.00% | 332K | |
+190.94% | 7.13B | |
+2.14% | 982M | |
+41.91% | 872M | |
+26.98% | 820M | |
+1.72% | 664M | |
+5.92% | 648M | |
-.--% | 600M | |
+3.61% | 503M | |
-.--% | 500M |
- Stock Market
- Equities
- OCLG Stock
- News Oncologix Tech, Inc.
- Oncologix Tech, Inc. Elects Wayne Erwin as Chairman and CEO